["Atypical" method for understanding dementia. How can studying epigenetics contribute?]

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Context:

• Neurodegenerative diseases, including Parkinson's disease (PD) and Alzheimer's disease (AD), are characterized by protein aggregation into inclusion bodies.
• Increased expression of aggregation-prone proteins, such as amyloid precursor protein (APP) in AD and alpha-synuclein (SNCA) in PD, is linked to disease pathology.
• Gene duplication (e.g., APP in Down syndrome, SNCA in familial PD) and promoter polymorphisms (e.g., SNCA in sporadic PD) demonstrate the role of gene expression levels in neurodegeneration.

Purpose:

• To explore the role of gene expression and epigenetic modifications in the pathogenesis of neurodegenerative disorders.
• To investigate potential novel causes of dementia and other neurodegenerative diseases through epigenetic studies.

Summary:

• Pathological hallmarks of neurodegeneration involve aggregated proteins, with increased gene expression of these proteins implicated in disease development.
• Evidence from genetic studies (gene duplications, polymorphisms) supports the link between elevated protein expression and neurodegenerative conditions.
• Epigenetic mechanisms, such as DNA methylation, can alter gene expression and are increasingly recognized as contributing factors in central nervous system disorders, with preliminary findings suggesting epigenetic abnormalities in the SNCA gene in Parkinson's disease.

Impact:

• Highlights the significance of gene expression levels in neurodegenerative disease etiology.
• Suggests that epigenetic dysregulation, specifically in genes like SNCA, represents a potential avenue for understanding and treating Parkinson's disease.
• Proposes that epigenetic research can uncover novel causes and therapeutic targets for dementia and other neurodegenerative disorders.